Share

April 2021; 11 (2) Case

Effects of COVID-19 “Sheltering in Place” on Activity in People With Multiple Sclerosis

Valerie J. Block, Riley Bove, Jeffrey M. Gelfand, Bruce A.C. Cree
First published September 28, 2020, DOI: https://doi.org/10.1212/CPJ.0000000000000982
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
691

Share

Article Information

vol. 11 no. 2 e216-e218
DOI: 
https://doi.org/10.1212/CPJ.0000000000000982
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • Received May 15, 2020
  • Accepted August 25, 2020
  • First Published September 28, 2020.

Article Versions

Copyright & Usage: 
© 2020 American Academy of Neurology

Author Disclosures

    1. Valerie J. Block, PT, DPTSc*,
    2. Riley Bove, MD, MMSc*,
    3. Jeffrey M. Gelfand, MD, MAS and
    4. Bruce A.C. Cree, MD, PhD, MAS
  1. Valerie J. Block, PT, DPTSc*,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. National Multiple Sclerosis Foundation, FG-1707-28624

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Riley Bove, MD, MMSc*,
    3. Scientific Advisory Boards:

    1. (1) Roche-Genentech (2) Sanofi Genzyme (3) Novartis (4) EMD Serono (5) Alexion (6) Pear Digital Therapeutics (7) Biogen

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. (1) Patent - selective estrogen receptor modulators and remyelination.

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1) Roche-Genentech (2) Sanofi Genzyme (3) Novartis (4) EMD Serono (5) Alexion (6) Pear Digital Therapeutics (7) Biogen

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) Commercial entity, Akili Interactive (2) Commercial entity, Roche Genentech

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. (1) UCSF Medical staff (10/2015-current)

    Research Support, Foundations and Societies:

    1. (1) National MS Society, Career Transition Award (2) National MS Society, Research Award (3) National MS Society, Pilot Grant (4) Hilton Foundation Research Grant (5) Sherak Foundation (6) National MS Society, Harry Weaver Award

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License fee payments, Technology or Inventions:

    1. (1) Patent - selective estrogen receptor modulators and remyelination.

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Jeffrey M. Gelfand, MD, MAS and
    4. Scientific Advisory Boards:

    1. DSMB for a National Institutes of Aging funded study.

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Dr. Gelfand is on the editorial advisory board of Neurology Neuroimmunology & Neuroinflammation. Dr. Gelfand's wife is an associate editor for JAMA Neurology.

    Patents:

    1. NONE

    Publishing Royalties:

    1. Honoraria from Dynamed Plus for editorial review. Dr. Gelfand's spouse has received honoraria from UpToDate.

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Consuling for Biogen and Alexion. His spouse has received consulting fees from Biohaven and Satsuma.

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Research support (to University of California, San Francisco) from Genentech. His spouse has received grant support from Amgen.

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. PI of an Institutional Clinician Training Award from the National MS Society.

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. Dr. Gelfand has received compensation for medical-legal consulting as an expert witness, and his spouse has also received personal compensation for medical- legal consulting as an expert witness.

  4. Bruce A.C. Cree, MD, PhD, MAS
    5. Scientific Advisory Boards:

    1. Akili, scientific advisory board chair

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. None

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Akili, Alexion, Atara, Biogen, EMD Serono, Novartis, Sanofi and TG Therapeutics

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. None

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Department of Neurology, Weill Institute for Neurosciences, MS and Neuroinflammation Clinic, University of California San Francisco.
  1. Correspondence
    Dr. Cree Bruce.Cree{at}ucsf.edu

Article usage

Article usage: September 2020 to October 2023

AbstractFullPdfSource
Sep 2020119010Highwire
Oct 2020481094Highwire
Nov 202092023Highwire
Dec 202092033Highwire
Jan 202158027Highwire
Feb 202137024Highwire
Mar 202143013Highwire
Apr 20211113549Highwire
May 2021826035Highwire
Jun 2021922229Highwire
Jul 202174218Highwire
Aug 202176232Highwire
Sep 202183821Highwire
Oct 202162631Highwire
Nov 202112535Highwire
Dec 20212266Highwire
Jan 202203010Highwire
Feb 202201811Highwire
Mar 202202813Highwire
Apr 202202214Highwire
May 202201310Highwire
Jun 20220710Highwire
Jul 20220112Highwire
Aug 2022047Highwire
Sep 202202420Highwire
Oct 202202110Highwire
Nov 202204815Highwire
Dec 20220256Highwire
Jan 202303510Highwire
Feb 202302611Highwire
Mar 2023054Highwire
Apr 20231513Highwire
May 20230912Highwire
Jun 2023084Highwire
Jul 202301111Highwire
Aug 20231612Highwire
Sep 2023062Highwire
Oct 20230144Highwire

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. [email protected]
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me

Recommended articles